Clinical trial

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)

NCT00069784

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-08-01

PhasePHASE3

Study timeline

Study start (unknown)2003-08-01Date precision: month

Registry last updated2013-01-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Non-Insulin-Dependentunresolved

Interventions

insulin glargine (HOE901)DRUG

omega-3 polyunsaturated fatty acids (PUFA)DRUG

reusable pen device for insulin injectionDEVICE

Sponsors & collaborators

Sanofilead sponsor

Population Health Research Institutecollaborator

Mapped research locations

SeoulSouth Korea1 BarcelonaSpain1 ParisFrance1 BerlinGermany1 MilanItaly1 MoscowRussia1 WarsawPoland1 BeijingChina1 BudapestHungary1 IstanbulTurkey (Türkiye)1 ViennaAustria1 Buenos AiresArgentina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00069784 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.